Rxsight Price Fair Value from 2010 to 2025

RXST Stock  USD 24.68  0.24  0.96%   
Rxsight Price Fair Value yearly trend continues to be comparatively stable with very little volatility. Price Fair Value is likely to outpace its year average in 2025. From the period from 2010 to 2025, Rxsight Price Fair Value quarterly data regression had mean square error of  4.64 and mean deviation of  2.73. View All Fundamentals
 
Price Fair Value  
First Reported
2010-12-31
Previous Quarter
4.75139355
Current Value
4.99
Quarterly Volatility
3.28013105
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 30.8 K, Net Interest Income of 9.9 M or Interest Income of 9.9 M, as well as many indicators such as Price To Sales Ratio of 9.07, Dividend Yield of 0.0 or PTB Ratio of 4.99. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.
  
Check out the analysis of Rxsight Correlation against competitors.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Latest Rxsight's Price Fair Value Growth Pattern

Below is the plot of the Price Fair Value of Rxsight over the last few years. It is Rxsight's Price Fair Value historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rxsight's overall financial position and show how it may be relating to other accounts over time.
Price Fair Value10 Years Trend
Slightly volatile
   Price Fair Value   
       Timeline  

Rxsight Price Fair Value Regression Statistics

Arithmetic Mean0.53
Coefficient Of Variation614.90
Mean Deviation2.73
Median(1.45)
Standard Deviation3.28
Sample Variance10.76
Range10.1486
R-Value0.77
Mean Square Error4.64
R-Squared0.60
Significance0.0004
Slope0.53
Total Sum of Squares161.39

Rxsight Price Fair Value History

2025 4.99
2024 4.75
2023 8.66
2022 3.9
2021 2.23
2020 -1.49

About Rxsight Financial Statements

Rxsight shareholders use historical fundamental indicators, such as Price Fair Value, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Price Fair Value 4.75  4.99 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.